Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

How is the extracellular matrix measured?

The extracellular matrix is measured by a combination of protein-level, transcript-level, mechanical and imaging readouts, with the choice of method determined by whether the question concerns composition, architecture,

peptides-pro Editorial

The extracellular matrix (ECM) is the non-cellular network of proteins and polysaccharides that surrounds cells in most tissues; it is also referred to as the extracellular matrix compartment, the interstitial matrix, and, for its basement-membrane subdomain, the basal lamina. It is not a single molecule but a class of assembled macromolecules, so it has no single sequence, formula or molecular weight. Measurement therefore proceeds component by component: fibrillar collagens, fibronectin, periostin, elastin, proteoglycans and glycosaminoglycans are each quantified by their own assays, and the assembled network is characterised separately by imaging and mechanical testing. In practice, ECM measurement spans four readout families — protein abundance and post-translational state, transcript abundance, spatial architecture, and mechanical or tensional state — and most published studies combine at least two.

The molecular work in this area centres heavily on integrin-mediated adhesion and on the matrix metalloproteinase and TGFβ-associated remodelling pathways, because these are the routes by which cells sense and alter the matrix around them.

Research Studies

Fibronectin tension and fibrotic ECM in idiopathic pulmonary fibrosis models

An in vitro fibrosis assay using patient-derived fibroblasts and the tension-sensitive fibronectin-binding peptide FnBPA5 was established to test whether ECM fibre tension tracks fibrosis progression. Multivalent binding of the peptide to fibronectin is impaired by fibre strain, so the readout reports the tensional state of the matrix rather than its abundance alone. The system was validated against known fibrosis biomarkers at the protein and mRNA levels [8]. This is an in vitro model; the peptide is a research reagent, not a clinical assay.

Periostin and integrin-JNK signalling in arrhythmogenic cardiomyopathy

Periostin (POSTN) is a multifunctional ECM protein. In myocardium from arrhythmogenic cardiomyopathy (ACM) mice and from patients with ACM, POSTN was significantly elevated. POSTN deficiency alleviated heart dysfunction, reduced cardiac fibrosis and improved survival in ACM mice. The protein was mainly derived from cardiac myofibroblasts and promoted cardiomyocyte necroptosis in vivo and in vitro, acting through integrin-JNK-RIP3-MLKL signalling, and induced CCL3 expression via an integrin-JNK-ETS2 route; CCL3 in turn activated cardiac macrophages, forming a feedforward loop [2]. Findings are from mouse models and cell culture.

Apabetalone and fibrotic activation of cardiac fibroblasts

Because ECM accumulation causes tissue fibrosis contributing to myocardial dysfunction and heart failure, and no approved anti-fibrotic therapeutic targets it, apabetalone — a clinical-stage BET inhibitor — was tested in cell models recapitulating cardiac fibrosis. Human immortalised cardiac fibroblasts, cryopreserved cardiac fibroblasts, and ex vivo cultured fibroblasts from patients undergoing bypass grafting were used [3]. This is a cell-model study; it does not establish an ECM measurement standard.

MAFF and contraction-induced transcription in skeletal muscle

MAFF, a small MAF transcription factor, was consistently induced by acute exercise in both human and mouse skeletal muscle, with induction restricted to muscles recruited by the exercise modality. In C2C12 cells, Maff was induced by in vitro electrical pulse stimulation. CRISPR/Cas9-mediated Maff knockout C2C12 cells showed reduced myogenic fusion with accumulation of unfused nuclei, and RNA sequencing revealed broad reprogramming in Maff-deficient myotubes [4]. This work concerns transcriptional remodelling of muscle rather than direct ECM quantification.

Graphene oxide-hydroxyapatite coatings and ECM protein interactions

Graphene oxide binds proteins strongly through its high surface area and oxygen functional groups but carries dose-dependent cytotoxicity, whereas hydroxyapatite is biocompatible but shows relatively weak protein-protein interactions at the molecular scale. Molecular docking, pharmacophore modelling and molecular dynamics simulations were used to explore interactions of GO, HA and GO-HA nanocomposites with ECM proteins at the implant-tissue interface [6]. This is computational and materials work, not a tissue measurement method.

Astrocyte versus fibroblast fibronectin matrix assembly

Fibrillar fibronectin matrix is the predominant ECM in most tissues, but in neural tissue it is limited to sites of tissue damage and disease. Primary cortical astrocytes were shown to produce fibronectin and assemble it into fibrils through a process that differs from fibroblast-driven assembly, and the effects of TGFβ on that assembly differed between the two cell types [12]. This is a cell-culture comparison.

Proteomic profiling of breast implant capsules

Mass spectrometry-based proteomics has been applied to characterise the capsule proteome and the foreign-body response around breast implants, as a proof of concept for deep proteomic profiling where standardised molecular methods to assess host response were lacking [10]. This is a tissue-proteomics approach to a specific implant capsule.

Serum BDNF, Pfirrmann grading and IL-1β in disc degeneration

A registered study examines the correlation between serum BDNF levels, Pfirrmann grading and IL-1β in intervertebral disc degeneration. BDNF expression has been confirmed within intervertebral disc tissue, with degenerated discs showing increased BDNF expression compared with normal discs, and expression reported to increase further with degeneration severity; disc degeneration is closely associated with intradiscal nerve ingrowth [5]. This is a clinical correlation study, not an ECM assay.

Matrix targets in cosmetic science

A review of molecular targets in cosmetic research covers telomerase, histone deacetylases (particularly sirtuins), matrix metalloproteinases, antioxidant enzymes, CD44 receptor, tyrosinase, microphthalmia-associated transcription factor and melanocortin receptors, all of which regulate processes including DNA repair, gene expression and ECM turnover [7]. This is a review of targets rather than a measurement protocol.

Bone aging as multiscale degeneration

Bone aging has been described not merely as bone mass loss but as a multi-level, networked degenerative phenomenon spanning molecular, cellular, tissue and system levels. At the macroscopic level it is characterised by declines in bone mass, microstructure and biomechanical properties [1]. This framing is relevant because bone ECM is assessed across those same levels.

Comparison of ECM measurement readouts

ReadoutWhat it reportsExample from the evidence
Protein abundance / localisationPresence and level of a specific ECM proteinPOSTN elevated in ACM myocardium [2]
Transcript abundanceGene expression of matrix componentsRNA sequencing in Maff-deficient myotubes [4]
Tension / mechanical stateStrain of matrix fibresFnBPA5 peptide binding in IPF fibroblast assay [8]
ProteomicsUnbiased protein composition of a tissueBreast implant capsule proteome [10]
Imaging / gradingStructural severityPfirrmann grading in disc degeneration [5]
Computational modellingPredicted protein-surface interactionsGO-HA docking and dynamics [6]

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only, and we do not provide dosing, diagnostic or medical guidance of any kind. Nothing on this page is a recommendation for use in a person. Anyone considering a compound for their own health should speak to a licensed clinician.

Sources

WhatsApp